[Guidelines for bronchial asthma prevent and management(2020 edition) Asthma group of Chinese Throacic Society].
[Guidelines for bronchial asthma prevent and management(2020 edition) Asthma group of Chinese Throacic Society].
复制标题
DOI：
10.3760/cma.j.cn112147-20200618-00721
复制
发表时间：
2020-12-12
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
支气管哮喘是一种常见的慢性呼吸道疾病。临床研究表明，哮喘的规范化诊断和治疗，特别是有效的管理，对改善哮喘的控制和患者的生活质量具有重要意义。《支气管哮喘防治指南（2020年版）》是在此前《中国哮喘防治指南》的基础上，结合近年来中国及其他国家/地区循证医学研究成果制定的。该指南旨在为提高中国医生对哮喘的认识和规范诊断和治疗提供指导性文件。
Bronchial asthma is a common chronic respiratory disease. Clinical studies have shown that standardized diagnosis and treatment of asthma, especially effective management, are important for improving the asthma control and the quality of life of patients. The guideline for the prevention and treatment of bronchial asthma (2020 edition) were based on the previous guidelines for the prevention and treatment of asthma in China and combined with the results of evidence-based medicine research at China and other countries/regiongs in recent years. The guideline is intended to provide guidance documents for improving the understanding and standardized diagnosis and treatment of asthma among medical doctors in China.